443 related articles for article (PubMed ID: 10623793)
1. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S
J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793
[TBL] [Abstract][Full Text] [Related]
2. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways.
Sato S; Nomura F; Kawai T; Takeuchi O; Mühlradt PF; Takeda K; Akira S
J Immunol; 2000 Dec; 165(12):7096-101. PubMed ID: 11120839
[TBL] [Abstract][Full Text] [Related]
3. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways.
Henneke P; Takeuchi O; Malley R; Lien E; Ingalls RR; Freeman MW; Mayadas T; Nizet V; Akira S; Kasper DL; Golenbock DT
J Immunol; 2002 Oct; 169(7):3970-7. PubMed ID: 12244198
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.
Takeuchi O; Hoshino K; Akira S
J Immunol; 2000 Nov; 165(10):5392-6. PubMed ID: 11067888
[TBL] [Abstract][Full Text] [Related]
5. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions.
Nishiguchi M; Matsumoto M; Takao T; Hoshino M; Shimonishi Y; Tsuji S; Begum NA; Takeuchi O; Akira S; Toyoshima K; Seya T
J Immunol; 2001 Feb; 166(4):2610-6. PubMed ID: 11160323
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and -independent pathways.
Hazeki K; Masuda N; Funami K; Sukenobu N; Matsumoto M; Akira S; Takeda K; Seya T; Hazeki O
Eur J Immunol; 2003 Mar; 33(3):740-7. PubMed ID: 12616494
[TBL] [Abstract][Full Text] [Related]
7. MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly?
Galanos C; Gumenscheimer M; Mühlradt P; Jirillo E; Freudenberg M
J Endotoxin Res; 2000; 6(6):471-6. PubMed ID: 11521073
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
9. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity.
Edelson BT; Unanue ER
J Immunol; 2002 Oct; 169(7):3869-75. PubMed ID: 12244184
[TBL] [Abstract][Full Text] [Related]
10. Discrimination of bacterial lipoproteins by Toll-like receptor 6.
Takeuchi O; Kawai T; Mühlradt PF; Morr M; Radolf JD; Zychlinsky A; Takeda K; Akira S
Int Immunol; 2001 Jul; 13(7):933-40. PubMed ID: 11431423
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals.
Feng CG; Scanga CA; Collazo-Custodio CM; Cheever AW; Hieny S; Caspar P; Sher A
J Immunol; 2003 Nov; 171(9):4758-64. PubMed ID: 14568952
[TBL] [Abstract][Full Text] [Related]
12. Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent.
Huang LY; Aliberti J; Leifer CA; Segal DM; Sher A; Golenbock DT; Golding B
J Immunol; 2003 Aug; 171(3):1441-6. PubMed ID: 12874236
[TBL] [Abstract][Full Text] [Related]
13. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
[TBL] [Abstract][Full Text] [Related]
14. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.
Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME
J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.
Takeuchi O; Sato S; Horiuchi T; Hoshino K; Takeda K; Dong Z; Modlin RL; Akira S
J Immunol; 2002 Jul; 169(1):10-4. PubMed ID: 12077222
[TBL] [Abstract][Full Text] [Related]
16. A lipoprotein family from Mycoplasma fermentans confers host immune activation through Toll-like receptor 2.
Seya T; Matsumoto M
Int J Biochem Cell Biol; 2002 Aug; 34(8):901-6. PubMed ID: 12007626
[TBL] [Abstract][Full Text] [Related]
17. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
Borsutzky S; Kretschmer K; Becker PD; Mühlradt PF; Kirschning CJ; Weiss S; Guzmán CA
J Immunol; 2005 May; 174(10):6308-13. PubMed ID: 15879130
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
Fortune SM; Solache A; Jaeger A; Hill PJ; Belisle JT; Bloom BR; Rubin EJ; Ernst JD
J Immunol; 2004 May; 172(10):6272-80. PubMed ID: 15128816
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.
Scanga CA; Aliberti J; Jankovic D; Tilloy F; Bennouna S; Denkers EY; Medzhitov R; Sher A
J Immunol; 2002 Jun; 168(12):5997-6001. PubMed ID: 12055206
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 2- and 6-mediated stimulation by macrophage-activating lipopeptide 2 induces lipopolysaccharide (LPS) cross tolerance in mice, which results in protection from tumor necrosis factor alpha but in only partial protection from lethal LPS doses.
Deiters U; Gumenscheimer M; Galanos C; Mühlradt PF
Infect Immun; 2003 Aug; 71(8):4456-62. PubMed ID: 12874325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
